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Summary 
Enteropathogenic Escherichia coli (EPEC) is a human intestinal pathogen and a major cause 
of diarrhoea, particularly among infants in developing countries. EPEC target the Map and 
EspF multifunctional effector proteins to host mitochondria – organelles that play crucial 
roles in regulating cellular processes such as programmed cell death (apoptosis). While both 
molecules interfere with the organelles ability to maintain a membrane potential, EspF plays 
the predominant role and is responsible for triggering cell death. To learn more about the 
Map-mitochondria interaction we studied Map localisation to mitochondria with purified 
mitochondria (from mammalian and yeast cells) and within intact yeast. This revealed that i) 
Map targeting is dependent on the predicted N-terminal mitochondrial targeting sequence, ii) 
the N-terminal 44 residues are sufficient to target proteins to mitochondria and iii) Map 
import involves the mitochondrial outer membrane translocase (Tom22 and Tom40), the 
mitochondrial membrane potential, and the matrix chaperone, mtHsp70. These results are 
consistent with Map import into the mitochondria matrix via the classical import mechanism. 
As all known Map-associated phenotypes in mammalian cells are independent of 
mitochondrial targeting this may indicate that import serves as a mechanism to remove Map 
from the cytoplasm thereby regulating cytoplasmic function. Intriguingly, Map, but not EspF, 
alters mitochondrial morphology with deletion analysis revealing important roles for residues 
101-152. Changes in mitochondrial morphology have been linked to alterations in the ability 
of these organelles to regulate cellular processes providing a possible additional role for Map 
import into mitochondria. 
 
Introduction 
Subversion of mitochondrial function appears to be an important pathogenic trait as an 
increasing number of pathogens are reported to target proteins to these organelles (Boya et al., 
2001; Blanke, 2005). For example, gram negative bacteria employ three distinct mechanisms 
to interfere with mitochondrial function using i) outer membrane proteins such as Neisseria 
gonorrhoeae PorB (Müller et al., 2000; 2002), Neisseria meningitidis PorB (Massari et al., 
2000) and Acinetobacter baumannii Omp38 (Choi et al., 2005) ii) secreted proteins such as 
Helicobacter pylori VacA (Galmiche et al., 2000; Willhite and Blanke, 2004), Clostridium 
difficile Toxin A (He et al., 2000), and Staphylococcus aureus -Toxin (Bantel et al., 2001; 
Essmann et al., 2003; Haslinger et al., 2003) and iii) the injection of proteins directly into the 
host cells such as the enteropathogenic E.coli (EPEC) Map (Kenny and Jepson, 2000) and 
EspF (Nougayrede and Donnenberg, 2004; Nagai et al., 2005) proteins. While little is known 
on how bacterial outer membrane or secreted proteins access mitochondria, EPEC employs a 
type III secretion system to deliver proteins directly into the host cytosol (Cossart and 
Sansonetti, 2004; Chen and Frankel, 2005; Dean et al., 2005). Moreover, the presence of N-
terminal mitochondrial targeting signal sequences (demonstrated and putative for EspF and 
Map, respectively; Kenny and Jepson, 2000; Nagai et al., 2005) indicates a likely exploitation 
of the endogenous import machinery utilised to translocate nuclear-encoded proteins into 
these organelles (Neupert, 1997; Rassow and Pfanner, 2000; Koehler, 2004; Wiedemann et 
al., 2004). Furthermore, the presence of putative mitochondrial import cleavage signal 
sequences at residues 41 and 101 of Map and EspF, respectively is indicative of import across 
the mitochondrial outer and inner membranes. Mitochondria are essential organelles as they 
not only generate energy (ATP) but also monitor cellular health to determine whether the cell 
should undergo programmed cell death (apoptosis). While interaction of both EPEC proteins 
disrupts mitochondria organelle membrane potential, EspF is reported to play the predominant 
role and is responsible for triggering cell death (Kenny and Jepson, 2000; Nougayrede and 
Donnenberg, 2004; Nagai et al., 2005). To gain insight into the role of Map targeting to 
mitochondria we set out to elucidate the mechanism of interaction, compartmental localisation  
and consequence of targeting on mitochondrial function.  
 
Results 
Map is imported across the outer membrane of mitochondria purified from mammalian cells 
Map is a small 203 amino acid protein whose N-terminal 41 residues are predicted to encode 
mitochondrial-targeting and -import cleavage signal sequences (Kenny and Jepson, 2000) 
indicating a likely mechanism to explain Map association with mitochondria following 
delivery into host cells by EPEC. To examine the functionality of these signals, Map was 
synthesized in the presence of 35S-labeled methionine (Met residue at positions 1, 7, 33, 38, 
43, 48, 96, 124) using reticulocyte lysates prior to incubation with mitochondria isolated from 
in vitro cultured mammalian (Jurkat) cells. Figure 1A reveals the synthesis of a radio-labelled 
protein of Map’s expected molecular mass with an incubation of 10 µg/ml (final conc.) 
proteinase K at 0°C sufficient to completely degrade this protein (Fig. 1A). Incubation of pre-
synthesized Map with mitochondria led to its co-localising with re-isolated mitochondria (Fig. 
1B) indicative of a specific interaction. Indeed, a subpopulation of this organelle-associated 
Map protein resisted proteinase K digestion (Fig. 1B; 20 µg/ml final conc.) indicating that 
Map accesses a protease excluded compartment. 
To investigate this interaction in detail a plentiful supply of mitochondria was purified 
from rat liver cells. Similar results were obtained with these mitochondria as pre-synthesized 
Map co-purified with re-isolated rat mitochondria of a subpopulation resisting protease 
digestion (Fig. 1C). Moreover, a proportion of this pool (~25%) survived protease digestion 
with organelles whose outer membrane integrity was compromised by osmotic shock 
treatment (Fig. 1C) indicative of import across or into the inner membrane. This interpretation 
was supported by finding that some Map, but not the co-synthesized mitochondrial outer 
membrane porin (VDAC), resisted protease digestion of digitonin-treated (solubilises the 
outer membrane) mitochondria (Fig. 1D). Furthermore, pre-treatment of mitochondria with 
valinomycin (dissipates mitochondrial membrane potential) prior to Map addition rendered 
the entire Map pool sensitive to protease degradation in osmotic shocked organelles (Fig. 1C) 
revealing the dependence of translocation into or across the inner membrane on the organelles 
retaining a membrane potential. Moreover, pre-treatment of mitochondria with trypsin 
indicated a role for outer membrane proteins in Map import as this treatment reduced the Map 
levels that resisted proteinase K digestion (Fig. 1E).  
 
Import of Map into the matrix of mitochondria purified from yeast 
Given the extensive use of yeast in elucidating the mechanism of mitochondrial import and 
availability of defined mutants in specific aspects of the process (Neupert, 1997) we 
performed detailed studies on the molecular mechanism of Map import with mitochondria 
purified from yeast. Import of radio-labelled Map into mitochondria isolated from 
Saccharomyces cerevisiae produced results mimicking those with mammalian cells with Map 
resisting protease digestion following incubation with intact organelles (Fig. 2A). Indeed, the 
resistance of entire mitochondrial-associated Map pool to protease digestion (Fig 2A, lane 1 
versus 2) reveals that Map import, like many mammalian mitochondrial import proteins 
(Rassow, 1999), is highly efficient with yeast mitochondria. Map was imported more 
efficiently into or across the inner membrane as proteinase K treatment failed to degrade Map 
even following disruption of outer membrane integrity by osmotic shock (Fig. 2A; lane 3 
versus 1). While valinomycin treatment did not affect Map association with mitochondria 
(Fig. 2A; lane 4 versus lane 1) it dramatically reduced, as observed with purified mammalian 
mitochondria (Fig. 1C), the amount that resisted protease digestion in intact organelles (Fig. 
2A; lane 5). The complete sensitivity of Map to proteinase K digestion in valinomycin treated 
mitochondria following osmotic shock treatment (Fig. 2A; lane 6), as with purified 
mammalian mitochondria (Fig. 1C), reiterated the importance of mitochondrial membrane 
potential in Map translocation across the outer membrane.  
Following an incubation of Map reticulocyte lysate with yeast mitochondria, 
subsequent electrophoresis revealed at higher resolution the import of two radio-labelled 
polypeptides (Fig. 2A). Given the small difference in apparent molecular mass it was likely 
that the faster migrating band arose due to synthesis from the second Map methionine (at 
residue 7). To verify this, Met 7 was substituted for an alanine and the resulting radio-labelled 
in vitro transcription/translation product was incubated with yeast mitochondria. The 
detection of a single band corresponding to the slower migrating form (Fig. 2B, lane 2) not 
only supported this supposition but also suggests that the N-terminal 7 residues are 
dispensable for import. As the Met to Ala substituted protein was efficiently imported into 
yeast mitochondria (Fig. 2C), the encoding plasmid was used in all subsequent in vitro 
transcription/translation import assays. 
To determine whether Map import leads to its insertion into the inner membrane, Map 
was expressed in Saccharomyces cerevisiae, mitochondria were isolated, sonicated and the 
resulting membrane vesicles separated by sucrose density centrifugation. While Map was 
evident within intact mitochondria it did not copurify with fractions containing the outer or 
inner mitochondrial membrane proteins, Tom40 or Tim23, respectively (Fig. 2D). The 
absence of Map from all of these fractions suggests that Map is not an integral membrane 
protein. These results are consistent with a lack of predicted transmembrane domains and a 
localisation into a non-membrane compartment within mitochondria. Importantly, the import 
characteristics of Map are similar in mitochondria purified from either yeast or mammalian 
cells and demonstrate that yeast is a suitable model to investigate the import process in more 
detail.  
 
Map import is dependent on the TOM import machinery and the mitochondrial chaperone, 
mtHsp70  
Nearly all endogenous mitochondrial proteins are encoded by the nuclear genome, 
synthesized as precursor proteins in the cytosol, and post-translationally imported. Protein 
translocation across the outer membrane is mediated by the TOM complex that comprises 
several different subunits (Neupert, 1997; Rassow and Pfanner, 2000; Koehler, 2004; 
Wiedemann et al., 2004). As the central pore-forming subunit of the TOM complex is Tom40 
(Hill et al., 1998) and the yeast strain tom40-4 exhibits a Tom40 defect (Krimmer et al., 
2001), Map import was assessed with mitochondria isolated from this mutant or the wild type 
strain (Fig. 3A). A reduction in Map import, similar to that observed with endogenous 
mitochondrial preproteins (Fig. 3A, right panel; Krimmer et al., 2001), indicated a central role 
for the TOM complex in Map import. Tom22 is a multifunctional organizer of this complex. 
Previous studies showed that in mitochondria lacking Tom22, the TOM complex dissociates 
completely. However, yeast mutants lacking Tom22 are viable (van Wilpe et al., 1999). 
Incubation of pre-synthesized Map with mitochondria from a tom22 deletion strain (van 
Wilpe et al., 1999) versus the parental wildtype strain confirmed the involvement of the TOM 
complex in Map import (Fig. 3B).  
Given our data indicating Map import into the matrix, we assessed the requirement for 
mtHsp70 - a soluble 70 kDa heat shock protein encoded by the ssc1 gene - which drives 
translocation across the inner membrane (Kang et al., 1990; Gambill et al., 1993; Voos et al., 
1993). Indeed, the very strong reduction in Map import into mitochondria isolated from the 
temperature-sensitive yeast strain ssc1-3 (Gambill et al., 1993) is consistent with Map import 
into the mitochondrial matrix (Fig. 3C). Thus, Map import into isolated yeast mitochondria 
occurs by a mechanism involving the TOM complex (Fig. 3A and B), the mtHsp70 chaperone 
(Fig. 3C) and requires that the organelles retain a membrane potential (Fig. 1C and 2A). 
 
The N-terminal 44 residues of Map are sufficient to target proteins to the mitochondria  
The N-terminus of Map resembles the presequences of precursor proteins that target 
mitochondrial matrix (Fig. 4A) as it carries several positively charged residues in the absence 
of negative charges and a putative mitochondrial import cleavage signal (Roise and Schatz, 
1988; Hartl et al., 1989; Kenny and Jepson 2000). Strikingly, Map homologues in closely 
related bacterial strains carry mutations in the sequence encoding the positive charges, though 
the absence of charge alterations is indicative of important conserved roles (Fig. 4A). 
Moreover, a helical wheel of the N-terminal residues of EPEC Map revealed a clustering of 
three positive charges (residues 10, 21 and 39) on one side of the helix (Fig. 4B) – another 
characteristic of mitochondrial targeting sequences. To test the functionality of this region in 
mitochondrial targeting the N-terminal 44 amino acids of Map were replaced with a single 
methionine and the resulting protein fused inframe to the green fluorescent protein (GFP). 
The resulting pre-synthesized Map(45-203)-GFP fusion protein did not gain access to a 
protease resistant compartment in purified yeast mitochondria unlike the full length Map(1-
203)-GFP fusion protein (Fig. 4C). Thus, the N-terminal 44 residues are crucial for Map 
import into mitochondria. 
To confirm the functionality of this targeting signal sequence in intact cells, various 
Map-GFP fusion proteins were expressed in yeast and the cellular location of GFP relative to 
Mitotracker-labelled mitochondria was examined by confocal microscopy. Figure 5A shows 
that deletion of the N-terminal 44 Map residues, Map(45-203)-GFP, resulted in a GFP 
staining pattern consistent with a cytoplasmic location. As predicted this fusion protein did 
not alter the mitochondria staining, however it altered their distribution with organelles 
appearing to be concentrated around the cell periphery. In contrast, expression of a Map(1-
44)-GFP fusion protein resulted in the co-localization of GFP and Mitotracker staining 
patterns without an obvious change in mitrochondrial morphology or cellular distribution 
(Fig. 5B). In contrast, Map(1-203)-GFP co-localization with mitotracker was linked to a 
dramatic change in mitochondrial morphology with these organelles evident in a number of 
foci (Fig. 5C) and indicative of fragmentation of the mitochondrial network. 
 
Map residues 101-152 are important for altering mitochondrial morphology  
To determine whether such morphological changes were specific to Map or simply a 
consequence of its reported ability to compromise the mitochondrial membrane potential, an 
EspF-GFP fusion was expressed in yeast. Thus, although EspF-GFP is a more potent inhibitor 
of mitochondria membrane potential (Nagai et al., 2005), expression of such a fusion protein 
in yeast failed to induce mitochondrial morphology changes (Fig. 6A). In an attempt to define 
the Map region responsible for altering mitochondrial morphology we assessed the effect of 
expressing Map-GFP fusions that carried deletions within the map gene sequence. Thus, the 
finding that a Map(1-100)-GFP fusion (Fig 6B) failed to induce morphological change, unlike 
a Map(1-152)-GFP fusion (Fig. 6C), revealed an important role for residues 101 to 152 in this 
process.  
 
Map causes a slow dissipation of the mitochondrial membrane potential 
Consistent with mammalian infection studies (Kenny and Jepson, 2000), Map interaction with 
mitochondria induced a slow loss of membrane potential in yeast cells as revealed by the 
reduced accumulation of the membrane potential-sensitive uptake of Mitotracker. To examine 
this in more detail Map(1-203)-GFP was expressed in yeast for 2, 4 and 16 hours before 
adding MitoTracker and visualising its co-localisation with the GFP signal. Whereas Map(1-
203)-GFP and Mitotracker patterns were initially co-incident in mitochondria showing the 
normal structure (Fig. 7A), the pattern was radically altered following a 4 hour expression 
with both signals coincident within small cytoplasmic-located punctuate compartments (Fig. 
7B). Prolonged expression (16 h) resulted in the complete loss of Mitotracker staining in the 
Map(1-203)-GFP-labelled structures (Fig. 7C) in contrast, to cells expressing Map(1-44)-GFP 
where mitochondria exhibited normal intact membrane potential and organelle morphology 
(Fig. 7D). 
 
Discussion 
An increasing number of viral and bacterial proteins are now recognised to target the 
mitochondria in their host species, where they can act as regulators of apoptosis indicating an 
important function in pathogenesis (Boya et al., 2001; 2004; Blanke et al., 2005). While little 
is known on how most of these factors enter host cells to gain access to mitochondria, the 
Map and EspF proteins of enteropathogenic E.coli are injected directly into the host 
cytoplasm via a type III secretion system (Kenny, 2002a, 2002b; Zaharik et al., 2002). While 
it is considered likely that the putative mitochondrial targeting signal sequence of Map, like 
that of EspF, would target these proteins for import, this aspect has not been investigated. 
Here we demonstrate that the putative Map mitochondrial targeting signal is indeed 
functional. The first 44 residues of Map are essential for targeting to yeast mitochondria and 
sufficient to target the GFP protein to these organelles. The relevance of this to Map import 
within mammalian cells was illustrated by the fact that pre-synthesized radio-labelled Map 
was similarly imported into mitochondria purified from cultured Jurkat, rat liver and yeast 
(Saccharomyces cerevisiae) cells. Moreover, the in vitro import system in fact mimics the in 
vivo situation given that Map is normally delivered directly into the host cytosol (Kenny and 
Jepson, 2000). The more efficient rapid import of Map into yeast mitochondria presumably 
reflects a recognised increased capacity of yeast mitochondria to import proteins of 
mammalian origin. This lends itself to a possible mechanism whereby the efficiency of Map 
import may be employed to limit and therefore regulate Map cytoplasmic functions such as 
it’s ability to trigger Cdc42-dependent actin rearrangements and disruption of epithelial 
barrier function (Kenny et al., 2002; Dean et al., 2004). Such a mechanism would not be 
unprecedented as under physiological conditions NADH-cytochrome b5 reductase 
accumulates in two different locations, with the distribution of the enzyme solely determined 
by the efficiency of translocation across the mitochondrial outer membrane (Hahne et al., 
1994). Interestingly, Map lacking the mitochondrial targeting sequence is significantly more 
toxic to yeast cells as compared to the complete protein (Fig. 8). Thus, it would appear that as 
with mammalian cells Map interacts with host cytoplasmic proteins with the inability to target 
mitochondria linked to a cytotoxic effect. This phenotype does not appear to be linked to 
fusing GFP to the C-terminus as a N-terminal GST-Map fusion protein (which does not target 
mitochondria) was also linked to yeast cytotoxity (Rodriguez-Escudero et al., 2005). The 
possible role of mitochondrial import in the regulation of EPEC effector protein functions 
within the cytoplasm is currently under investigation. 
In vitro import and biochemical localisation assays were consistent with Map 
translocation across both the outer and inner mitochondrial membranes in a manner involving 
the TOM import machinery, the matrix import chaperone mtHsp70 and the organelles 
possessing a membrane potential. Indeed, a requirement for membrane potential for Map 
association with mitochondria following EPEC delivery into mammalian mitochondria 
(Kenny and Jepson, 2000) supports the relevance of these studies to mammalian cells. These 
results are consistent with Map accessing the mitochondrial matrix according to the principles 
established for uptake of endogenous proteins (Neupert, 1997; Rassow and Pfanner, 2000; 
Wiedemann et al., 2004) and represent the first study to delineate the mechanism by which a 
bacterial effector molecule becomes incorporated into mitochondria. It should be noted that 
while Map encodes a predicted import cleavage signal sequence (CSS) we failed to detect a 
corresponding cleavage product, in contrast to within EPEC-infected cells (Kenny and Jepson, 
2000). This discrepancy may reflect inefficient recognition of mammalian CSS in yeast 
mitochondria. However, it is also possible that the cleavage evident within infected cells is 
not related to the mitochondrial presequence peptidase. 
 The role of Map interaction with mitochondria is currently a puzzle given that another 
EPEC effector, EspF, also targets mitochondria and is reportedly the predominant effector 
involved in disrupting organelle mitochondrial membrane potential and triggering cell death 
(Nagai et al., 2005; Crane et al., 2001; Nougayrede and Donnenberg, 2004). While it is 
possible that mitochondrial import may simply act to regulate Map cytoplasmic activities, the 
identification of a specific effect for Map, and not EspF, on yeast mitochondrial morphology 
indicates a specific function within these organelles. Moreover, analysis of various Map 
deletions revealed a role for residues 101-152, but not 1-44 or 153-203, in inducing these 
morphological changes.  
These Map-mediated morphological changes resemble those observed with yeast 
mutants altered in the mitochondrial fusion and fission process. Importantly, such changes in 
morphology are now recognised to affect the ability of mitochondria to regulate cellular 
processes such as inheritance of mitochondria DNA, transmission of energy and cellular 
differentiation (Shaw and Nunnari, 2002; Mozdy and Shaw, 2003; Osteryoung and Nunnari, 
2003; Pfanner et al., 2004). Strikingly, a direct link between mitochondrial fragmentation and 
apoptosis has recently been reported in Caenorhabditis elegans (Jagasia et al., 2005; Youle, 
2005) and mitochondrial fusion/fission reportedly controls apoptosis in mammalian cells 
(Bossy-Wetzel et al., 2003; Perfettini et al., 2005). Given EspF’s linkage to an increased 
apoptotic index within the gastrointestinal tract of mice infected with the mouse specific 
EPEC-like strain it is tempting to speculate that Map may play an anti-apoptotic role that 
serves to limit the pro-apoptotic effect of EspF. Alternatively, Map alteration of mitochondrial 
morphology may function to modulate other mitochondrial-controlled cellular process. 
Further studies with intact mammalian cells are underway to investigate the consequence of 
Map import into the mitochondria matrix on organelle morphology and function, in the 
presence and absence of the co-targeted EspF protein.  
 
Experimental procedures 
 
For bacterial strains, plasmids and oligonucleotides, see Table 1. 
 
Construction of plasmids 
pGEM-4/Map was generated by cloning a Map-encoding fragment (derived from the 
pathogenicity island of EPEC wildtype strain E2348/69) into the vector pGEM-4, using an 
EcoRI site upstream of the start codon and a PstI site downstream of the stop codon. For the 
construction of plasmids encoding Map-GFP, Map(45-203)-GFP, Map(1-100)-GFP or 
Map(1-152)-GFP, the corresponding Map sequence was amplified by PCR using pGEM-
4/Map as a template and the oligonucleotide pairs listed in Table 1. These oligonucleotides 
were designed to delete the Map stop codon and introduce upstream HindIII and downstream 
BamHI or SacI restriction sites. In the case of Map(45-203)-GFP, an additional start codon 
was introduced by the forward oligonucleotide. DNA fragments were cleaved with 
HindIII/BamHI or HindIII/SacI, respectively, and cloned into the pYES2 plasmid containing 
the GFP sequence between BamHI and XhoI. For the generation of a plasmid encoding 
Map(1-44)-GFP, two complementary oligonucleotides encoding for the first 44 amino acids 
of Map were hybridized, resulting in a DNA fragment with an upstream HindIII and 
downstream BamHI overhang. pGEM-4/Map-M7A was obtained by site-directed mutagenesis 
using the oligonucleotide pair listed in Table 1 and the pGEM-4/Map plasmid as a template. 
 
Isolation and fractionation of mitochondria 
For isolation of mitochondria, yeast cells were grown in YPG medium (1% (w/v) yeast 
extract, 2% (w/v) bacto-peptone, pH 5.0, containing 3% (v/v) glycerol) as described 
previously (Rassow, 1999). Strains requiring a fermentable carbon source were grown in YPD 
medium (1% (w/v) yeast extract, 2% (w/v) bacto-peptone, pH 5.0, containing 2% (w/v) 
glucose). Strains containing a pYES2 plasmid were grown in synthetic minimal medium 
lacking uracil and containing 2% (v/v) raffinose. The expression of the GFP hybrid proteins 
was induced by isolation of the cells and subsequent growth in synthetic minimal medium 
lacking uracil in the presence of 2% (v/v) galactose. The isolation of yeast mitochondria 
followed standard procedures (Rassow et al., 1999). Isolated yeast mitochondria were 
suspended in SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS-KOH, pH 7.2) at a 
concentration of 10 mg protein/ml and stored at –80°C. 
Rat liver mitochondria were obtained by the homogenization of rat liver pieces in 
buffer A (300 mM sucrose, 2 mM EGTA, 10 mM Tris-HCl pH7.4) containing BSA (5 mg/ml) 
and 1mM PMSF. Cell debris was removed by centrifugation at 500 g for 10 min. (All 
centrifugation steps were carried out at 4°C using a Beckman Avanti J-25 centrifuge and a 
JA-25.50 rotor). The supernatant was then centrifuged at 12000 g for 6 min to obtain a crude 
fraction of mitochondria. For further purification, the mitochondria were subsequently 
resuspended in 12 ml buffer A, and Percoll (Sigma, P1644) was added to a final concentration 
of 5% (v/v). The mitochondria were pelleted by centrifugation at 16.000 g for 10 min. The 
mitochondria were washed once in buffer A and eventually resuspended in buffer A (f.c. 10 
mg/ml). Mitochondria of Jurkat cells were isolated as published previously (Müller et al. 
2000).  
 
Import of proteins in isolated mitochondria 
Radiolabeled precursor proteins were synthesized in rabbit reticulocyte lysate (TNT T7 
Coupled Reticulocyte Lysate System, Promega, L4610) in the presence of 35S-labeled 
methionine (ICN Biomedical Research Products, Eschwege, Germany). The proteins were 
imported into isolated mitochondria in samples of 50-100 µl as described previously (Rassow, 
1999). In standard assays, the samples contained BSA buffer (3% [w/v] BSA, 80 mM KCl, 10 
mM MOPS-KOH, pH 7.2), 2 µl reticulocyte lysate, 2 mM NADH, 1 mM ATP, 20 mM 
potassium phosphate and 30 µg (yeast mitochondria) or 40 µg (mammalian mitochondria) 
mitochondrial protein. All import reactions were carried out at 25°C. The uptake of 
preproteins was stopped by addition of proteinase K at a final concentration of 20 µg/ml. 
Following an incubation for 10 min at 0°C, the protease was inactivated by 2 mM PMSF and 
an additional incubation for 5 min at 0°C. To dissipate the membrane potential, valinomycin 
(Sigma, V-0627) was used at a final concentration of 1 µM. The reagent was added from a 
100fold concentrated stock solution in ethanol. 
To determine the localization of proteins inside mitochondria, the isolated organelles 
were fractionated essentially following standard procedures (Rassow, 1999). The outer 
membrane was opened by incubation of the mitochondria in 10 mM MOPS-KOH pH 7.2. 
Alternatively, digitonin (Calbiochem, No. 3004) was added up to a final concentration of 0.4 
% (w/v). For preparation of membrane vesicles, mitochondria (2 mg protein in 200 Rl SEM) 
were mixed with 200 Rl 0.6 M Sorbitol, 20 mM HEPES-KOH pH7.4 and incubated for 5 min 
at 0°C. 2.6 ml 0.5 M EDTA, 20 mM HEPES-KOH pH7.4 and 100 mM PMSF were added for 
swelling of the mitochondria. Following an incubation for 30 min at 0°C, a mixture of 
protease inhibitors was added. Swelling was stopped by the addition of sucrose to a final 
concentration of 1.8 M and an additional incubation for 10 min. Membrane vesicles were 
formed by sonication using a sonifier (Branson 250; duty cycle 70%, Output control 3). Each 
sample was treated with 3 cycles of each 30 sec. sonification and 15 sec., using a 3 mm 
Microtip (Heinemann, Schwäbisch Gmünd). Vesicles of inner and outer membrane were 
separated by sucrose density centrifugation (Rassow, 1999; Sickmann et al., 2003). The 
suspension of vesicles obtained by sonification was centrifuged for 10 min at 16.000 g to 
remove residual mitochondria. The vesicles were pelleted at 160.000 g (30 min., 4°C). The 
membranes were carefully resuspended in 400 Rl 10 mM KCl, 5 mM HEPES-KOH pH7.4 
and 100 mM PMSF. The suspension was centrifuged for 10 min at 16.000 g to remove 
aggregates. The supernatant was applied on a step gradient of 0.85, 1.1, 1.35 and 1.6 M 
sucrose in 100 mM KCl, 5 mM HEPES-KOH pH 7.4 in a total volume of 11 ml, using Ultra-
Clear centrifuge tubes (Beckman, 14 x 95 mm, No. 344060), prior to centrifugation for 16 h at 
100.000 g using a SW41 rotor (Beckman, 30.000 rpm, 4°C). 1 ml fractions were collected for 
precipitation with trichloracetic acid (10% v/v final conc.) and SDS-PAGE. 
 
Microscopy 
Yeast cultures expressing GFP hybrid proteins were directly stained in the medium by the 
addition of MitoTracker Orange CMTMRos (Molecular Probes, M-7510) to a final 
concentration of 50 nM and incubation for at least 30 min at 30°C. After the staining 
procedure, yeast cells were washed in PBS (150 mM NaCl, 20 mM sodium phosphate, pH 
7.4), transferred to polylysinated object slides (Sigma-Aldrich, P0425) and incubated for 15 
min in the dark (reduce fluorescent fading) to allow the cells to sediment. Yeast cells were 
then imaged by Confocal Laser Scanning Microscopy (CLSM) using a Leica TCS SP2 
Confocal Laser Scanning Microscope on a DM RE microscope stand. The system was run 
with Leica LCS software (version 2.61 Build 1537). Images were recorded with a 100 x oil 
immersion objective using a zoom factor of 4 and sequential scanning with the 488-nanometer 
spectral line of an argon-ion laser (GFP) and the 543-nanometer line from a green helium-
neon laser (MitoTracker Orange). GFP fluorescence was detected from 559 to 686 nm, 
MitoTracker Orange fluorescence from 500 to 600 nm. Obtained images were filtered with a 
Median filter (radius 1 pixel) to reduce noise and levels and contrast was adjusted 
automatically or manually with Photoshop software (Adobe, USA).  
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Figure legends 
 
Figure 1. Role for membrane potential and outer membrane proteins in the import of Map 
into a protease resistant compartment of mammalian mitochondria. A. 35S-labeled Map was 
synthesized in reticulocyte lysate and incubated for 10 min at 0°C with proteinase K (PK) at 
indicated concentrations prior to addition of PMSF to inactivate the protease. Aliquots were 
analysed by SDS-PAGE prior to visualisation by fluorography (top panel) or quantification of 
Map band using a phosphorimager (bottom panel). The amount of Map in the absence of PK 
was set to 100% (control). B. 35S-labeled Map was incubated with freshly isolated 
mitochondria from Jurkat cells for 10 min at 25°C. Duplicate samples were cooled to 0°C, 
one treated with PK (20 µg/ml final conc.) and mitochondria reisolated (10 min at 16.000 x g) 
for SDS-PAGE analysis and fluorography. C. Radiolabeled Map was incubated with isolated 
rat liver mitochondria for 10 min at 25°C. One sample contained valinomycin (Val) to 
dissipate the membrane potential. The samples were cooled on ice and duplicates exposed to 
osmotic shock to disrupt outer membrane integrity (swelling, SW) prior to proteinase K 
digestion and reisolation of the mitochondria. The relative amounts of imported Map were 
visualised by SDS-PAGE and fluorography prior to quantification using a phosphorimager. 
The highest amount of PK-protected Map was set to 100%. D. Radiolabeled Map and host 
mitochondrial outer membrane porin were synthesized in reticulocyte lysates and incubated 
with purified mitochondria from rat liver, prior to reisolation and incubation in the absence 
(lane 1) or presence of 0.4 % digitonin for 15 min at 0°C (lane 2). The samples were diluted 
20 fold with SEM buffer, incubated with PK (20 µg/ml final conc.) prior to re-isolating 
mitochondria and visualising Map by SDS-PAGE and fluorography. E. Mitochondria from rat 
livers were incubated for 10 min at 0°C in the presence of trypsin (20 µg/ml final conc.) or 
left without trypsin, prior to adding trypsin inhibitor and incubating with 35S-labeled Map for 
indicated times. The mitochondria were then treated with PK, reisolated and the relative 
amounts of Map determined. Defined aliquots of the reticulocyte lysate were included in 
SDS-PAGE analyses as references to determine the ratio of imported Map in relation to the 
total amounts of Map. 
Figure 2. Import of radiolabeled Map into isolated yeast mitochondria. A. Map was 
synthesized in reticulocyte lysate in the presence of 35S-labeled methionine and incubated 
with mitochondria isolated from the yeast Saccharomyces cerevisiae (wildtype, PK82). 
Samples were incubated in the presence (+) or absence (-) of valinomycin (Val) to dissipate 
membrane potential prior to disrupting (+) or not (-) outer membrane integrity by osmotic 
shock (swelling, SW). Mitochondria were subsequently treated in the presence (+) or absence 
(-) of proteinase K (PK; 20 µg/ml final conc.), prior to reisolation and SDS-PAGE analysis. 
Radiolabeled Map was visualized by fluorography. B. Map was synthesized using plasmids 
encoding the native Map (lane 1) or Methionine (residue 7) to an Alanine substituted Map 
(Map-M7A; lane 2) prior to visualising products by SDS-PAGE and fluorography. C. 35S-
labeled Map-M7A was incubated with yeast mitochondria and the percentage of protease 
resistant Map determined. D. Map was expressed in yeast prior to isolating mitochondria, 
disrupting by sonication and separating membrane vesicles by sucrose density centrifugation. 
Resulting fractions were separated by SDS-PAGE and probed for the location of the 
mitochondrial outer and inner membrane proteins Tom40 and Tim23, respectively as well as 
Map. Lanes 1-10, sucrose gradient fractions; lane 11, sample of isolated mitochondria; lane 
12, mitochondrial sample from yeast not expressing Map. 
 
Figure 3. Translocation of Map across the mitochondrial membranes. A. 35S-labeled Map was 
synthesized in reticulocyte lysate and incubated (25°C for indicated time) with mitochondria 
isolated form wildtype yeast (wt) or a corresponding strain carrying a defect in Tom 40 
(tom40-4). Mitochondria of the same preparation were tested for import of mitochondrial 
outer membrane porin (right panel). B. Import of radiolabeled Map into yeast mitochondria 
lacking Tom22 (tom22). C. Import of Map into mitochondria carrying a defect in the matrix 
chaperone mtHsp70 (ssc1-3). Samples were cooled on ice and incubated with proteinase K 
(20 µg/ml final conc) prior to reisolating and determining the relative amount of Map 
quantified using a phosphorimager of bands visualised by SDS-PAGE and fluorography. The 
highest value was set to 100% (control).  
 
Figure 4. The Map N-terminus acts as a mitochondrial targeting sequence. A. Map N-
terminal amino acid sequences from EPEC strain (E2348/69) and the closely related rabbit 
(RDEC-1) and mouse (Citrobacter rodentium)-specific strains. B. N-terminal residues 10-39 
of EPEC Map as a helical wheel projection reveals clustering of positive charges. C. 35S-
labeled Map(1-203)-GFP and Map(45-203)-GFP fusion proteins were incubated (25°C for 
indicated time) with isolated yeast mitochondria prior to adding proteinase K (20 µg/ml final 
conc.) and reisolating mitochondria. The relative amount of Map was visualised by SDS-
PAGE and fluorography prior to quantifying using a phosphorimager. The highest value was 
set to 100% (control).  
Figure 5. The predicted Map mitochondrial targeting sequence is necessary and sufficient for 
import, with Map import altering mitochondrial morphology. Plasmids encoding various 
portions of Map fused in frame to the green fluorescent protein (GFP) were introduced into 
the wildtype yeast Saccharomyces cerevisiae strain BY4742. Cells were grown overnight in 
raffinose-containing synthetic minimal medium lacking uracil and expression of A) Map(45-
203)-GFP, B) Map(1-44)-GFP and C) Map(1-203)-GFP induced for 4 h by the addition of 
galactose. Mitochondria were labelled by incubating with MitoTracker Orange CMTMRos. 
Cells were examined by confocal microscopy to reveal the location of GFP (left panel) and 
MitoTracker (central panel). Merged images are shown in the right panel. Thus, Map(45-
203)-GFP, in contrast to Map(1-44)-GFP, does not target mitochondria. Import of Map(1-
203)-GFP leads to the alteration of mitochondrial morphology as evidenced by the presence 
of GFP and Mitotracker signals in punctuate structures throughout the cytosol. 
 
Figure 6. Alteration of mitochondria morphology is not mediated by EspF and involves Map 
residues 101-152. Plasmids encoding A) EspF(1-206)-GFP B) Map(1-100)-GFP or C) Map(1-
152)-GFP fusion proteins were introduced into wildtype yeast Saccharomyces cerevisiae 
strain BY4742. Cells were grown overnight in raffinose-containing synthetic minimal 
medium lacking uracil and plasmid gene expression induced by adding galactose. Following a 
4 hr expression, mitochondria were labelled with MitoTracker Orange CMTMRos and cells 
examined by the confocal microscope to reveal the location of GFP (left panel), MitoTracker 
(central panel), and merged signals (right panel). Thus, while both EspF(1-206)-GFP and 
Map(1-100)-GFP target mitochondria, the morphology of the mitochondria was  unaltered. 
However, expression of Map(1-152)-GFP changes the pattern, with both GFP and Mitotracker 
signals in punctuate structures. 
 
Figure 7. Map-mediated loss of mitochondrial membrane potential is subsequent to 
morphology alterations. Wildtype yeast, Saccharomyces cerevisiae strain BY4742, carrying a 
plasmid encoding Map(1-203)-GFP or Map(1-44)-GFP were grown overnight in raffinose-
containing synthetic minimal medium lacking uracil with plasmid gene expression induced by 
adding galactose. Whereas Map(1-203)-GFP is evidently co-localising with mitochondria 
following a 2hr expression (A), co-incident morphological chances in GFP and Mitotracker 
signals is only evident following a 4hr expression (B). However, 16 h post-expression cells 
carrying small fragmented mitochondria fail to label with Mitotracker revealing the loss of 
mitochondrial membrane potential (C). The specific nature of this was revealed by the fact 
that similar experiments with Map(1-44)-GFP failed to induce such alterations (D). 
 
Figure 8. Failure to target Map to mitochondria inhibits yeast cell growth. Plasmids encoding 
either Map(1-203)-GFP or Map(45-203)-GFP were introduced into wildtype yeast strain 
BY4742. Cells were grown overnight in synthetic minimal medium (lacking uracil) 
containing raffinose as a carbon source. Starting with cultures of the same cell density, 
dilution steps were performed as indicated. 5Rl of each dilution were placed on an agar 
minimal medium plate containing galactose to induce protein expression. 
 
Table 1. Strains, plasmids and oligonucleotides used in this study
Yeast strains
BY4742 MAT; his31; leu20; lys20; ura30 Brachmann et al., 1998
PK82 MAT; his4-713; lys2; ura3-52; trp1; leu2-3 Gambill et al., 1993
ssc1-3 MAT; ade2-101; lys2; ura3-52; trp1; leu2-3,112; ssc1-3::LEU2 Gambill et al., 1993
OL223 MAT; his3-200; leu2-1; ura3-52; trp1-63; rho0 van Wilpe et al., 1999
OL201 (tom22) MAT; his3-200; leu2-1; ura3-52; trp1-63; tom22::HIS3; rho0 van Wilpe et al., 1999
KKY3.7 (TK8) MAT; his3-200; leu2-3,112; ade2-101; suc2-9; trp1-901; ura3-52; tom40::HIS3 (pRS314-TOM40) Krimmer et al., 2001
KKY3.4 (TK5) (tom40-4) MAT; his3-200; leu2-3,112; ade2-101; suc2-9; trp1-901; ura3-52; tom40::HIS3 (pRS314-tom40-4) Krimmer et al., 2001
Plasmids
pGEM-4 (Promega) select with ampicillin (100 Rg ml-1 final concentration)
pYES2 (Invitrogen) select with ampicillin (100 Rg ml-1 final concentration)
Oligonucleotides
Map(1-203)-GFP-fw 5´ CAA GCT TAC CAT GTT TAG TCC AAT GA 3´
Map(1-203)-GFP-rev 5´ CAA GGA GCT CCA ACC GAG TAT ACT GTA C 3´
Map(45-203)-GFP-fw 5´ CGC GAA GCT TAG CAT GTC GAA CCT TAT GAT TAA TC 3´
Map(45-203)-GFP-rev 5´ CTA GAG CTC CAG CCG AGT ATC CTG CAC ATT GTC 3´
Map(1-100)-GFP-fw 5´ TAT TAA GCT TAT GTT TAG TCC AAC GGC AAT G 3´
Map(1-100)-GFP-rev 5´ ACT GGA TCC CGA ATT ATT ACT CAT GC 3´
Map(1-152)-GFP-fw 5´ TAT TAA GCT TAT GTT TAG TCC AAC GGC AAT G 3´
Map(1-152)-GFP-rev 5´ ATC GGA TCC TTT ACC ACA CTG C 3´
Map-Met7Ala-fw 5´ GTT TAG TCC AAC GGC AAT GGT AGG TAG AGC GTT AG 3´
Map-Met7Ala-rev 5´ CTA ACG CTC TAC CTA CCA TTG CCG TTG GAC TAA AC 3´
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